Arca Biopharma | ABIO - Interest Expense On Debt


Arca Biopharma reported $504K in Interest Expense on Debt for its fiscal quarter ending in September of 2024.





Interest Expense On Debt Change Date
Amgen USD 657M 4M Mar/2026
Arca Biopharma USD 504K 246K Sep/2024
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 411M 21M Mar/2026
Capricor Therapeutics 3.05M 2.46M Dec/2025
Cipla INR 131.3M 9M Mar/2026
Compugen USD 954K 116K Sep/2025
CSL USD 215M 111M Dec/2025
Cytokinetics USD 33.34M 3M Mar/2026
Daiichi Sankyo JPY 2.16B 1.33B Dec/2025
Gilead Sciences USD 240M 15M Mar/2026
GlaxoSmithKline GBP 167M 21M Mar/2026
Grifols EUR 156.07M 31.46M Sep/2025
Laboratory Of America USD 55.1M 100K Mar/2026
Myriad Genetics USD 4.4M 600K Dec/2025
Otsuka Holdings JPY 2.21B 866M Dec/2025
Pfizer USD 671M 40M Mar/2026
United Therapeutics USD 3.1M 100K Dec/2025